Jill Daley

Associate

Jill Daley

Toronto

T:+1 416.216.1930

F:+1 416.216.3930

Jill Daley practises intellectual property, regulatory and commercial law as a barrister and solicitor. In addition, Ms. Daley is a licensed and practising pharmacist in Ontario with experience in community pharmacy, long-term care, addiction treatment and consulting.

She has experience in a wide range of matters involving the innovative pharmaceutical, biotechnology, natural health product, medical device and cosmetic industries, including pre-clinical and clinical trial applications, packaging, labelling, advertising and marketing practices, submissions and responses to the Common Drug Review and the Patented Medicine Prices Review Board, provincial listing agreements, formulary listing, interchangeability decisions under Ontario’s Drug Interchangeability and Dispensing Fee Act and Ontario Drug Benefit Act as well as proceedings under the Patented Medicines (Notice of Compliance) Regulations. As part of her practice, Ms. Daley advises on the practice of regulated health professionals in Ontario.

Ms. Daley’s counsel to clients includes developing industry-specific compliance programs, document management, and third-party responses to access requests. She advises clients on various privacy issues pursuant to the federal Personal Information Protection and Electronic Documents Act as well as provincial legislation pertaining to personal information and personal health information.

Ms. Daley advises on all aspects of advertising and marketing law for consumer products, including advertisement review (print, broadcast and internet), review of contests, coupon and premium promotions, packaging and labelling requirements, comparative claim and advertising support. Ms. Daley also includes representing clients in trade dispute proceedings administered by Advertising Standards Canada and the Pharmaceutical Advertising Advisory Board.

As part of her practice, Ms. Daley assists clients in dealing with regulatory and pre-clearance agencies, such as Health Canada, the Health Products and Food Branch Inspectorate, the Patented Medicine Prices Review Board (PMPRB), the Ontario Public Drug Plans, the Pharmaceutical Advertising Advisory Board (PAAB), the Canadian Agency for Drugs and Technology and the Office of Information and Privacy Commissioner/Ontario as well as advising on judicial review of these agencies’ decisions.

[+Open all]
  • Year of call
    Ontario 2008
  • Law school
    LL.B., Queen's University, 2007
  • Education
    Registered Pharmacist (Part A), Ontario College of Pharmacists, 2003
    B.Sc., Pharmacy, Dalhousie University, 2003
  • Speaking engagements
    • “What Medical Device Stakeholders Are…And Should Be Talking About” (panel discussion), FDLI Medical Device Regulation and Litigation Conference, June 18, 2012.
    • “The Future of Clinical Trial Contracting in Canada: The Canadian Model Clinical Trial Agreement Experience,” MAGI Clinical Research Conference, May 22, 2012.
    • “Medical Devices in Canada – A Regulatory Overview,” Ontario Institute for Cancer Research, March 7, 2012.
    • “Regulatory Law in the Pharmaceutical Industry: Recent Developments” (guest lecturer), Regulatory Affairs for Industry Program, Humber College, February 27, 2012; February 28, 2011; February 11, 2008.
    • “Canadian Drug Regulation & the Pharmaceutical Industry” (guest lecturer), University of Waterloo, Faculty of Pharmacy, February 1, 2012.
    • “Medical Device Classification and the Future Outlook of the Canadian Healthcare System for Medical Devices,” Canadian Medical Device Market Access and Government Affairs Conference, December 5, 2011.
    • “Social Media: Regulatory and IP Issues in the Pharmaceutical Industry” and “Price Regulation, Innovative Drugs, and The Patented Medicine Prices Review Board – An Overview,” National Pharmaceutical Sciences Group, PSG Certification Program, June 16, 2011.
    • “In-Depth Look at the Legal and Realistic Challenges of PMPRB Developments and How it is Going to Affect the Canadian Pharmaceutical Industry,” Canadian Pharmaceutical Pricing and Reimbursement Conference, December 2, 2010.
    • “Ontario Drug Pricing Reform - The Truth Behind the News Stories,” Ontario Bar Association (OBA) Health Law, November 25, 2010.
    • “Intellectual Property & Regulatory Law in the Pharmaceutical Industry - A Year in Review” (guest lecturer), Canadian Association of Professional Regulatory Affairs (CAPRA) Education Day-2010, June 1, 2010.
  • Selected client work
    • Regulatory counsel in the merger of Valeant Pharmaceuticals and Biovail Corporation
    • Regulatory counsel in matters relating to the integration of Merck Frosst Canada Inc. and Schering Plough Canada Inc.
    • Member of the litigation team representing Pfizer Canada Inc. in a successful judicial review application challenging the Patented Medicine Prices Review Board (Pfizer Canada Inc. v Attorney General of Canada, 2009 FC 719 (T-1442-08))
    • Canadian counsel to Warner Chilcott plc in its acquisition and financing of Procter & Gamble's worldwide pharmaceuticals business for US$3.1 billion
  • Rankings and recognitions
    • Dean’s Key, Faculty of Law, Queen's University
    • Centennial Scholar, Canadian Pharmacists Association
    • Loran National Scholar, Canadian Merit Scholarship Foundation
    • International Leadership Award, Canadian Pharmacists Association
    • Commitment to Care Award, Pharmacy Practice
    • J.G. Senior Stick Award, College of Pharmacy, Dalhousie University
  • Memberships and activities
    • Canadian Bar Association
    • Law Society of Upper Canada
    • Ontario Bar Association
      • Health Law Section Executive
      • Privacy Law Section Executive
    • Toronto Intellectual Property Group
    • Ontario College of Pharmacists (R.Ph.)
    • Ontario Pharmacists Association
    • Canadian Pharmacists Association
  • Directorships
    • Past member, Board of Directors, Canadian Pharmacists Association